Michael L. Manning - Concepedia

Author

Michael L. Manning

Also Known As

Michael L Manning, Michael L. Manning, Michael Manning

Publications

485

Citations

H-Index

Concepts

All Affiliations

Michael L. Manning is an author at United States Food and Drug Administration specializing in immunology, medicine, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	91
2	Natural Sciences	1	1	28
3	Biochemistry	1	1	28
4	Cell Biology	1	1	28
5	Clinical Immunology	1	1	12

Michael L. Manning

Publications

406

Citations

H-Index

Page 1

	Year	Citations
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia Aviva C. Krauss, Xin Gao, Liang Li, Clinical Cancer Research	2018	315
An FDA oncology analysis of immune activating products and first-in-human dose selection Haleh Saber, Ramadevi Gudi, Michael L. Manning, Regulatory Toxicology and Pharmacology Fda Oncology AnalysisCancer ImmunosurveillanceMedicineFirst-in-human Dose SelectionImmunology	2016	51
Proteolysis of Complement Factors iC3b and C5 by the Serine Protease Prostate-Specific Antigen in Prostatic Fluid and Seminal Plasma Michael L. Manning, Simon A. Williams, Christine Jelinek, The Journal of Immunology ImmunologyPathologyComplement Factors Ic3bImmune SystemTumor Biology	2013	28
Bortezomib Reduces Pre-Existing Antibodies to Recombinant Immunotoxins in Mice Michael L. Manning, Emily Mason‐Osann, Masanori Onda, The Journal of Immunology Clinical ImmunologyAb ResponseAutoimmune DiseaseImmunotoxicologyNeutralizing Abs	2015	12

Page 1